NEWS
December 22, 2021
PGV completes Series B by raising 150 million yen through third-party allotment of new shares to Shionogi & Co., Ltd. (Osaka) this month.
October 14, 2021
Series B third-party allotment of new shares covered in the newspaper media
August 31, 2021
August 31, 2021. PGV raises 300 million yen through third-party allotment of new shares to enterprises, including Shionogi & Co., Ltd. (Osaka).
February 10, 2021
PGV adopted for a NEDO's program, "2020 Innovation Promotion Project for Accelerating AI Chip Development."
NEDO (New Energy and Industrial Technology Development Organization) adopted PGV’s proposal for "2020 Innovation Promotion Project for Accelerating AI Chip Development.” In this project, PGV plans to improve the productivity of the AI development environments by developing "pre-processing chips," equipped with data pre-processing technology, and "brain wave AI development tools."
December 1, 2020
PGV concludes a joint research agreement with Osaka University.
PGV and Osaka University agree to jointly research and develop diagnostic technology for neurological diseases such as dementia using PGV patch-type EEG.
August 20, 2020
PGV obtains License Certificate for Selling and Leasing Specially-Controlled Medical Device on August 17, 2020.
August 19, 2020
PGV obtains a medical device certification for “Patch-Type EEG HARU-1.”
July 14, 2020
PGV raises 150 million yen through third-party allotment of new shares to OSAKA University Venture Capital Co., Ltd.
March 13, 2020